Fellows E

General Adult Psychiatry and Health Systems Division, Centre for Addiction and Mental Health, Canada; and Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Canada.

2 papers

ArticlePsilocybin

Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial.

Husain MI, Blumberger DM, Castle DJ +8

Europe PMC2023
ArticlePsilocybin

Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?

Husain MI, Ledwos N, Fellows E +5

Europe PMC2022